What is Dravet Syndrome?
Bright Minds Biosciences recently announced significant progress with BMB-101 as a potentially effective treatment for Dravet Syndrome. Because this rare form of epilepsy is not well understood, our Chief Medical Officer, Dr. Revati Shreeniwas, MD, FCCP, prepared this background. Dravet Syndrome is a rare form of severe pharmacoresistant epilepsy with onset in early childhood.…
